Survivorship: Childhood Cancer Survivors

Primary Care - Clinics in Office Practice

Volumn 36, Issue 4, 2009, Pages 743-780

  Oeffinger, Kevin C ^a   Hudson, Melissa M ^b   Landier, Wendy ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Childhood cancer; Children's Oncology Group; Late effects; Neoplasm; Screening; Surveillance; Survivors

Indexed keywords

ASPARAGINASE; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; PROCARBAZINE; TIOGUANINE; VINBLASTINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; CANCER CENTER; CANCER SURVIVOR; CASE REPORT; CHILD; CHILDHOOD CANCER; DISEASE SEVERITY; FEMALE; HIGH RISK POPULATION; HODGKIN DISEASE; HUMAN; INTERDISCIPLINARY COMMUNICATION; MALE; MORBIDITY; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; THERAPY EFFECT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; INFANT; MALE; NEOPLASMS; PARENTS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PRIMARY HEALTH CARE; QUALITY ASSURANCE, HEALTH CARE; SURVIVORS; UNITED STATES;

EID: 71849091937     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2009.07.007     Document Type: Review

References (186)

1. In: Hewitt M., Weiner S.L., and Simone J.V. (Eds). Childhood cancer survivorship: improving care and quality of life (2003), The National Academies Press, Washington, DC. 20-36
2. Geenen M.M., Cardous-Ubbink M.C., Kremer L.C., et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 297 24 (2007) 2705-2715
3. Meadows A.T., Friedman D.L., Neglia J.P., et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 27 14 (2009) 2356-2362
4. Oeffinger K.C., Mertens A.C., Sklar C.A., et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355 15 (2006) 1572-1582
5. Mertens A.C., Liu Q., Neglia J.P., et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 100 19 (2008) 1368-1379
6. Hudson M.M., Mertens A.C., Yasui Y., et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA 290 12 (2003) 1583-1592
7. Ness K.K., Mertens A.C., Hudson M.M., et al. Limitations on physical performance and daily activities among long-term survivors of childhood cancer. Ann Intern Med 143 9 (2005) 639-647
8. Landier W., Bhatia S., Eshelman D.A., et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22 24 (2004) 4979-4990
9. Eshelman D., Landier W., Sweeney T., et al. Facilitating care for childhood cancer survivors: integrating Children's Oncology Group long-term follow-up guidelines and health links in clinical practice. J Pediatr Oncol Nurs 21 5 (2004) 271-280
10. Poplack D.G., Fordis M., Horowitz M.E., et al. Improving the lives of childhood cancer survivors: development of a novel Internet resource for managing long-term health risks. In: Hewitt M. (Ed). Implementing cancer survivorship care planning (2007), The National Academies Press, Washington, DC 206-241
11. Nathan P.C., Greenberg M.L., Ness K.K., et al. Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 26 27 (2008) 4401-4409
12. Oeffinger K.C., Mertens A.C., Hudson M.M., et al. Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Fam Med 2 1 (2004) 61-70
13. Nathan P.C., Ford J.S., Henderson T.O., et al. Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort. J Clin Oncol 27 14 (2009) 2363-2373
14. Robison L.L., Mertens A.C., Boice J.D., et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol 38 4 (2002) 229-239
15. Perkins J.L., Liu Y., Mitby P.A., et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 23 16 (2005) 3733-3741
16. Fletcher B.D. Effects of pediatric cancer therapy on the musculoskeletal system. Pediatr Radiol 27 8 (1997) 623-636
17. Mulhern R.K., Merchant T.E., Gajjar A., et al. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 5 7 (2004) 399-408
18. Reimers T.S., Ehrenfels S., Mortensen E.L., et al. Cognitive deficits in long-term survivors of childhood brain tumors: Identification of predictive factors. Med Pediatr Oncol 40 1 (2003) 26-34
19. Mulhern R.K., Hancock J., Fairclough D., et al. Neuropsychological status of children treated for brain tumors: a critical review and integrative analysis. Med Pediatr Oncol 20 3 (1992) 181-191
20. Mitby P.A., Robison L.L., Whitton J.A., et al. Utilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 97 4 (2003) 1115-1126
21. Mulhern R.K., Palmer S.L., Merchant T.E., et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 23 24 (2005) 5511-5519
22. Ris M.D., Packer R., Goldwein J., et al. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. J Clin Oncol 19 15 (2001) 3470-3476
23. Cousens P., Waters B., Said J., et al. Cognitive effects of cranial irradiation in leukaemia: a survey and meta-analysis. J Child Psychol Psychiatry 29 6 (1988) 839-852
24. Langer T., Martus P., Ottensmeier H., et al. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory. Med Pediatr Oncol 38 5 (2002) 320-328
25. Waber D.P., Tarbell N.J., Fairclough D., et al. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice. J Clin Oncol 13 10 (1995) 2490-2496
26. Gurney J.G., Kadan-Lottick N.S., Packer R.J., et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 97 3 (2003) 663-673
27. Laughton S.J., Merchant T.E., Sklar C.A., et al. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol 26 7 (2008) 1112-1118
28. Sklar C.A. Growth and neuroendocrine dysfunction following therapy for childhood cancer. Pediatr Clin North Am 44 2 (1997) 489-503
29. Hew F.L., O'Neal D., Kamarudin N., et al. Growth hormone deficiency and cardiovascular risk. Baillieres Clin Endocrinol Metab 12 2 (1998) 199-216
30. Rose S.R., Danish R.K., Kearney N.S., et al. ACTH deficiency in childhood cancer survivors. Pediatr Blood Cancer 45 6 (2005) 808-813
31. Oeffinger K.C., Mertens A.C., Sklar C.A., et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 21 7 (2003) 1359-1365
32. Garmey E.G., Liu Q., Sklar C.A., et al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 26 28 (2008) 4639-4645
33. Janiszewski P.M., Oeffinger K.C., Church T.S., et al. Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. J Clin Endocrinol Metab 92 10 (2007) 3816-3821
34. Oeffinger K.C., Adams-Huet B., Victor R.G., et al. Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 27 (2009) 3698-3704
35. Gurney J.G., Ness K.K., Stovall M., et al. Final height and body mass index among adult survivors of childhood brain cancer: Childhood Cancer Survivor Study. J Clin Endocrinol Metab 88 10 (2003) 4731-4739
36. Bowers D.C., Liu Y., Leisenring W., et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol 24 33 (2006) 5277-5282
37. Packer R.J., Gurney J.G., Punyko J.A., et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: Childhood Cancer Survivor Study. J Clin Oncol 21 17 (2003) 3255-3261
38. Neglia J.P., Robison L.L., Stovall M., et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98 21 (2006) 1528-1537
39. Bhatia S., Yasui Y., Robison L.L., et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 21 23 (2003) 4386-4394
40. Kenney L.B., Yasui Y., Inskip P.D., et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 141 8 (2004) 590-597
41. Taylor A.J., Winter D.L., Stiller C.A., et al. Risk of breast cancer in female survivors of childhood Hodgkin's disease in Britain: a population-based study. Int J Cancer 120 2 (2007) 384-391
42. Cutuli B., Borel C., Dhermain F., et al. Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases. Radiother Oncol 59 3 (2001) 247-255
43. Wolden S.L., Hancock S.L., Carlson R.W., et al. Management of breast cancer after Hodgkin's disease. J Clin Oncol 18 4 (2000) 765-772
44. Oeffinger K.C., Ford J.S., Moskowitz C.S., et al. Breast cancer surveillance practices among women previously treated with chest radiation for a pediatric cancer. JAMA 301 4 (2009) 404-414
45. Hull M.C., Morris C.G., Pepine C.J., et al. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 290 21 (2003) 2831-2837
46. Swerdlow A.J., Higgins C.D., Smith P., et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst 99 3 (2007) 206-214
47. Reinders J.G., Heijmen B.J., Olofsen-van Acht M.J., et al. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol 51 1 (1999) 35-42
48. Aleman B.M., van den Belt-Dusebout A.W., De Bruin M.L., et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109 5 (2007) 1878-1886
49. Orzan F., Brusca A., Conte M.R., et al. Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment. Br Heart J 69 6 (1993) 496-500
50. Adams M.J., Lipshultz S.E., Schwartz C., et al. Radiation-associated cardiovascular disease: manifestations and management. Semin Radiat Oncol 13 3 (2003) 346-356
51. Heidenreich P.A., Schnittger I., Strauss H.W., et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol 25 1 (2007) 43-49
52. Adams M.J., Hardenbergh P.H., Constine L.S., et al. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 45 1 (2003) 55-75
53. Bowers D.C., McNeil D.E., Liu Y., et al. Stroke as a late treatment effect of Hodgkin's disease: a report from the Childhood Cancer Survivor Study. J Clin Oncol 23 27 (2005) 6508-6515
54. King L.J., Hasnain S.N., Webb J.A., et al. Asymptomatic carotid arterial disease in young patients following neck radiation therapy for Hodgkin lymphoma. Radiology 213 1 (1999) 167-172
55. Mah K., Van Dyk J., Keane T., et al. Acute radiation-induced pulmonary damage: a clinical study on the response to fractionated radiation therapy. Int J Radiat Oncol Biol Phys 13 2 (1987) 179-188
56. Morgan G.W., Freeman A.P., McLean R.G., et al. Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 11 11 (1985) 1925-1931
57. Mefferd J.M., Donaldson S.S., and Link M.P. Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy. Int J Radiat Oncol Biol Phys 16 3 (1989) 679-685
58. Ng A.K., Li S., Neuberg D., et al. A prospective study of pulmonary function in Hodgkin's lymphoma patients. Ann Oncol 19 10 (2008) 1754-1758
59. Mertens A.C., Yasui Y., Liu Y., et al. Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study. Cancer 95 11 (2002) 2431-2441
60. van Leeuwen F.E., Somers R., Taal B.G., et al. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. J Clin Oncol 7 8 (1989) 1046-1058
61. Travis L.B., Gospodarowicz M., Curtis R.E., et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 94 3 (2002) 182-192
62. Hancock S.L., Cox R.S., and McDougall I.R. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 325 9 (1991) 599-605
63. Sklar C., Whitton J., Mertens A., et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 85 9 (2000) 3227-3232
64. Sigurdson A.J., Ronckers C.M., Mertens A.C., et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet 365 9476 (2005) 2014-2023
65. Metayer C., Lynch C.F., Clarke E.A., et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18 12 (2000) 2435-2443
66. Bassal M., Mertens A.C., Taylor L., et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 24 3 (2006) 476-483
67. Tefft M. Radiation related toxicities in National Wilms' Tumor Study Number 1. Int J Radiat Oncol Biol Phys 2 5-6 (1977) 455-463
68. Deeg H.J. Delayed complications after hematopoietic cell transplantation. In: Thomas E.D., Blume K.G., and Forman S.J. (Eds). Hematopoietic cell transplantation. 2nd edition (1999), Blackwell Science, Malden (MA) 776-788
69. Coleman C.N., McDougall I.R., Dailey M.O., et al. Functional hyposplenia after splenic irradiation for Hodgkin's disease. Ann Intern Med 96 1 (1982) 44-47
70. Jones D.P., Spunt S.L., Green D., et al. Renal late effects in patients treated for cancer in childhood: a report from the Children's Oncology Group. Pediatr Blood Cancer 51 6 (2008) 724-731
71. Cohen E.P. Radiation nephropathy after bone marrow transplantation. Kidney Int 58 2 (2000) 903-918
72. Moulder J.E., Fish B.L., and Cohen E.P. Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonists. Curr Pharm Des 13 13 (2007) 1317-1325
73. Yeung C.K., Ward H.C., Ransley P.G., et al. Bladder and kidney function after cure of pelvic rhabdomyosarcoma in childhood. Br J Cancer 70 5 (1994) 1000-1003
74. Hale G.A., Marina N.M., Jones-Wallace D., et al. Late effects of treatment for germ cell tumors during childhood and adolescence. J Pediatr Hematol Oncol 21 2 (1999) 115-122
75. Chemaitilly W., Mertens A.C., Mitby P., et al. Acute ovarian failure in the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 91 5 (2006) 1723-1728
76. Sklar C. Maintenance of ovarian function and risk of premature menopause related to cancer treatment. J Natl Cancer Inst Monographs 34 (2005) 25-27
77. Sklar C. Growth and endocrine disturbances after bone marrow transplantation in childhood. Acta Paediatr Suppl 411 (1995) 57-61 [discussion: 62]
78. Sklar C.A., Mertens A.C., Mitby P., et al. Premature menopause in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98 13 (2006) 890-896
79. Bisharah M., and Tulandi T. Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol 188 2 (2003) 367-370
80. Williams R.S., Littell R.D., and Mendenhall N.P. Laparoscopic oophoropexy and ovarian function in the treatment of Hodgkin disease. Cancer 86 10 (1999) 2138-2142
81. Green D.M., Whitton J.A., Stovall M., et al. Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol 187 4 (2002) 1070-1080
82. Signorello L.B., Cohen S.S., Bosetti C., et al. Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst 98 20 (2006) 1453-1461
83. Thomson A.B., Wallace W.H., and Sklar C.A. Testicular function. In: Wallace W.H., and Green D.M. (Eds). Late effects of childhood cancer (2004), Arnold Publishers, London (UK) 239-253
84. Rovo A., Tichelli A., Passweg J.R., et al. Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD. Blood 108 3 (2006) 1100-1105
85. Howell S.J., and Shalet S.M. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst 34 (2005) 12-17
86. Sklar C.A., Robison L.L., Nesbit M.E., et al. Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children Cancer Study Group. J Clin Oncol 8 12 (1990) 1981-1987
87. Shalet S.M., Tsatsoulis A., Whitehead E., et al. Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol 120 1 (1989) 161-165
88. Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol 33 1 (1999) 2-8
89. Izard M.A. Leydig cell function and radiation: a review of the literature. Radiother Oncol 34 1 (1995) 1-8
90. Farber S., and Diamond L.K. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N Engl J Med 238 23 (1948) 787-793
91. Meadows A.T., and D'Angio G.J. Late effects of cancer treatment: methods and techniques for detection. Semin Oncol 1 1 (1974) 87-90
92. Critchley H.O. Ovarian and uterine function and reproductive potential. In: Wallace H., and Green D. (Eds). Late effects of childhood cancer (2004), Arnold, London 225-238
93. Sklar C., Boulad F., Small T., et al. Endocrine complications of pediatric stem cell transplantation. Front Biosci 6 (2001) G17-G22
94. Bath L.E., Wallace W.H., and Critchley H.O. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. BJOG 109 2 (2002) 107-114
95. Wallace W.H., Shalet S.M., Lendon M., et al. Male fertility in long-term survivors of childhood acute lymphoblastic leukaemia. Int J Androl 14 5 (1991) 312-319
96. Kenney L.B., Laufer M.R., Grant F.D., et al. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer 91 3 (2001) 613-621
97. Dann E.J., and Rowe J.M. Biology and therapy of secondary leukaemias. Best Pract Res Clin Haematol 14 1 (2001) 119-137
98. Bhatia S., and Sklar C. Second cancers in survivors of childhood cancer. Nat Rev Cancer 2 2 (2002) 124-132
99. Pedersen-Bjergaard J., and Larsen S.O. Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease. N Engl J Med 307 16 (1982) 965-971
100. Godley L.A., and Larson R.A. Therapy-related myeloid leukemia. Semin Oncol 35 4 (2008) 418-429
101. Hinkle A.S., Proukou C., and Chen Y. Pulmonary effects of antineoplastic therapy. In: Schwartz L., Hobbie W., Constine L.S., et al. (Eds). Survivors of childhood and adolescent cancer: a multidisciplinary approach (2005), Springer, New York 161-179
102. Levine L.A., and Richie J.P. Urological complications of cyclophosphamide. J Urol 141 5 (1989) 1063-1069
103. Sarosy G. Ifosfamide-pharmacologic overview. Semin Oncol 16 1 Suppl 3 (1989) 2-8
104. Samra Y., Hertz M., and Lindner A. Urinary bladder tumors following cyclophosphamide therapy: a report of two cases with a review of the literature. Med Pediatr Oncol 13 2 (1985) 86-91
105. Burk C.D., Restaino I., Kaplan B.S., et al. Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor. J Pediatr 117 2 Pt 1 (1990) 331-335
106. Krischer J.P., Epstein S., Cuthbertson D.D., et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol 15 4 (1997) 1544-1552
107. Adams M.J., and Lipshultz S.E. Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention. Pediatr Blood Cancer 44 7 (2005) 600-606
108. Kremer L.C., van Dalen E.C., Offringa M., et al. Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Ann Oncol 13 4 (2002) 503-512
109. Kremer L.C., van der Pal H.J., Offringa M., et al. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol 13 6 (2002) 819-829
110. Iarussi D., Indolfi P., Casale F., et al. Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management. Paediatr Drugs 7 2 (2005) 67-76
111. Lipshultz S.E., Lipsitz S.R., Sallan S.E., et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23 12 (2005) 2629-2636
112. Von Hoff D.D., Layard M.W., Basa P., et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91 5 (1979) 710-717
113. Hudson M.M., Rai S.N., Nunez C., et al. Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors. J Clin Oncol 25 24 (2007) 3635-3643
114. Sorensen K., Levitt G.A., Bull C., et al. Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study. Cancer 97 8 (2003) 1991-1998
115. van Dalen E.C., van der Pal H.J., Kok W.E., et al. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. Eur J Cancer 42 18 (2006) 3191-3198
116. Levitt G.A., Dorup I., Sorensen K., et al. Does anthracycline administration by infusion in children affect late cardiotoxicity?. Br J Haematol 124 4 (2004) 463-468
117. Poutanen T., Tikanoja T., Riikonen P., et al. Long-term prospective follow-up study of cardiac function after cardiotoxic therapy for malignancy in children. J Clin Oncol 21 12 (2003) 2349-2356
118. Rammeloo L.A., Postma A., Sobotka-Plojhar M.A., et al. Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group. Med Pediatr Oncol 35 1 (2000) 13-19
119. Pan P.H., and Moore C.H. Doxorubicin-induced cardiomyopathy during pregnancy: three case reports of anesthetic management for cesarean and vaginal delivery in two kyphoscoliotic patients. Anesthesiology 97 2 (2002) 513-515
120. Gilsanz V. Bone density in children: a review of the available techniques and indications. Eur J Radiol 26 2 (1998) 177-182
121. van der Sluis I.M., Boot A.M., Hop W.C., et al. Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study. Horm Res 58 5 (2002) 207-214
122. van der Sluis I.M., van den Heuvel-Eibrink M.M., Hahlen K., et al. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 35 4 (2000) 415-420
123. van der Sluis I.M., van den Heuvel-Eibrink M.M., Hahlen K., et al. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 141 2 (2002) 204-210
124. Arikoski P., Komulainen J., Riikonen P., et al. Reduced bone density at completion of chemotherapy for a malignancy. Arch Dis Child 80 2 (1999) 143-148
125. Brennan B.M., Mughal Z., Roberts S.A., et al. Bone mineral density in childhood survivors of acute lymphoblastic leukemia treated without cranial irradiation. J Clin Endocrinol Metab 90 2 (2005) 689-694
126. Kadan-Lottick N., Marshall J.A., Baron A.E., et al. Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998. J Pediatr 138 6 (2001) 898-904
127. Kaste S.C., Jones-Wallace D., Rose S.R., et al. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia 15 5 (2001) 728-734
128. Warner J.T., Evans W.D., Webb D.K., et al. Relative osteopenia after treatment for acute lymphoblastic leukemia. Pediatr Res 45 4 Pt 1 (1999) 544-551
129. Mandel K., Atkinson S., Barr R.D., et al. Skeletal morbidity in childhood acute lymphoblastic leukemia. J Clin Oncol 22 7 (2004) 1215-1221
130. Nysom K., Holm K., Michaelsen K.F., et al. Bone mass after treatment for acute lymphoblastic leukemia in childhood. J Clin Oncol 16 12 (1998) 3752-3760
131. Mattano Jr. L.A., Sather H.N., Trigg M.E., et al. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol 18 18 (2000) 3262-3272
132. Sala A., Mattano Jr. L.A., and Barr R.D. Osteonecrosis in children and adolescents with cancer-an adverse effect of systemic therapy. Eur J Cancer 43 4 (2007) 683-689
133. Arico M., Boccalatte M.F., Silvestri D., et al. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 88 7 (2003) 747-753
134. Ribeiro R.C., Fletcher B.D., Kennedy W., et al. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia 15 6 (2001) 891-897
135. Burger B., Beier R., Zimmermann M., et al. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)-experiences from trial ALL-BFM 95. Pediatr Blood Cancer 44 3 (2005) 220-225
136. Strauss A.J., Su J.T., Dalton V.M., et al. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 19 12 (2001) 3066-3072
137. Relling M.V., Yang W., Das S., et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol 22 19 (2004) 3930-3936
138. Knight K.R., Kraemer D.F., and Neuwelt E.A. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol 23 34 (2005) 8588-8596
139. Hilkens P.H., and ven den Bent M.J. Chemotherapy-induced peripheral neuropathy. J Peripher Nerv Syst 2 4 (1997) 350-361
140. Ellis P.A., Fitzharris B.M., George P.M., et al. Fasting plasma lipid measurements following cisplatin chemotherapy in patients with germ cell tumors. J Clin Oncol 10 10 (1992) 1609-1614
141. Pui C.H., Ribeiro R.C., Hancock M.L., et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 325 24 (1991) 1682-1687
142. Trimble E.L., Ungerleider R.S., Abrams J.A., et al. Neoadjuvant therapy in cancer treatment. Cancer 72 11 Suppl (1993) 3515-3524
143. Heyn R., Raney Jr. R.B., Hays D.M., et al. Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol 10 4 (1992) 614-623
144. Jockovich M., Mendenhall N.P., Sombeck M.D., et al. Long-term complications of laparotomy in Hodgkin's disease. Ann Surg 219 6 (1994) 615-621 [discussion: 621-4]
145. Nagarajan R., Neglia J.P., Clohisy D.R., et al. Limb salvage and amputation in survivors of pediatric lower-extremity bone tumors: what are the long-term implications?. J Clin Oncol 20 22 (2002) 4493-4501
146. Kaste S.C., Neel M.N., Rao B.N., et al. Complications of limb-sparing procedures using endoprosthetic replacements about the knee for pediatric skeletal sarcomas. Pediatr Radiol 31 2 (2001) 62-71
147. Eiser C., Darlington A.S., Stride C.B., et al. Quality of life implications as a consequence of surgery: limb salvage, primary and secondary amputation. Sarcoma 5 4 (2001) 189-195
148. Renard A.J., Veth R.P., Schreuder H.W., et al. Function and complications after ablative and limb-salvage therapy in lower extremity sarcoma of bone. J Surg Oncol 73 4 (2000) 198-205
149. Bailey S., Roberts A., Brock C., et al. Nephrotoxicity in survivors of Wilms' tumours in the North of England. Br J Cancer 87 10 (2002) 1092-1098
150. Gutierrez-Millet V., Nieto J., Praga M., et al. Focal glomerulosclerosis and proteinuria in patients with solitary kidneys. Arch Intern Med 146 4 (1986) 705-709
151. Bhisitkul D.M., Morgan E.R., Vozar M.A., et al. Renal functional reserve in long-term survivors of unilateral Wilms tumor. J Pediatr 118 5 (1991) 698-702
152. Finklestein J.Z., Norkool P., Green D.M., et al. Diastolic hypertension in Wilms' tumor survivors: a late effect of treatment? A report from the National Wilms' Tumor Study Group. Am J Clin Oncol 16 3 (1993) 201-205
153. Ritchey M.L., Green D.M., Thomas P.R., et al. Renal failure in Wilms' tumor patients: a report from the National Wilms' Tumor Study Group. Med Pediatr Oncol 26 2 (1996) 75-80
154. Breslow N.E., Norris R., Norkool P.A., et al. Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol 21 24 (2003) 4579-4585
155. Breslow N.E., Takashima J.R., Ritchey M.L., et al. Renal failure in the Denys-Drash and Wilms' tumor-aniridia syndromes. Cancer Res 60 15 (2000) 4030-4032
156. Breslow N.E., Collins A.J., Ritchey M.L., et al. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol 174 5 (2005) 1972-1975
157. Andrassy R.J., Hays D.M., Raney R.B., et al. Conservative surgical management of vaginal and vulvar pediatric rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study III. J Pediatr Surg 30 7 (1995) 1034-1036 [discussion: 1036-7]
158. Hays D.M., Raney R.B., Wharam M.D., et al. Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy, with or without radiotherapy. A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee. J Pediatr Hematol Oncol 17 1 (1995) 46-52
159. Heyn R., Newton W.A., Raney R.B., et al. Preservation of the bladder in patients with rhabdomyosarcoma. J Clin Oncol 15 1 (1997) 69-75
160. Spunt S.L., Sweeney T.A., Hudson M.M., et al. Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors. J Clin Oncol 23 28 (2005) 7143-7151
161. Kalloo N.B., Jeffs R.D., and Gearhart J.P. Long-term nutritional consequences of bowel segment use for lower urinary tract reconstruction in pediatric patients. Urology 50 6 (1997) 967-971
162. Raney Jr. B., Heyn R., Hays D.M., et al. Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate. A report from the Intergroup Rhabdomyosarcoma Study Committee. Cancer 71 7 (1993) 2387-2394
163. Ejstrud P., Kristensen B., Hansen J.B., et al. Risk and patterns of bacteraemia after splenectomy: a population-based study. Scand J Infect Dis 32 5 (2000) 521-525
164. Sumaraju V., Smith L.G., and Smith S.M. Infectious complications in asplenic hosts. Infect Dis Clin North Am 15 2 (2001) 551-565 x
165. Holdsworth R.J., Irving A.D., and Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 78 9 (1991) 1031-1038
166. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. BMJ 312 7028 (1996) 430-434
167. Waghorn D.J., and Mayon-White R.T. A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed?. J Infect 35 3 (1997) 289-294
168. Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 40 RR-13 (1991) 1-25
169. Centers for Disease Control. Recommendations for prevention and control of hepatitis C Virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 47 RR-19 (1998) 1-39
170. Donahue J.G., Munoz A., Ness P.M., et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 327 6 (1992) 369-373
171. Castellino S., Lensing S., Riely C., et al. The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the
172. Locasciulli A., Testa M., Pontisso P., et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 90 11 (1997) 4628-4633
173. Paul I.M., Sanders J., Ruggiero F., et al. Chronic hepatitis C virus infections in leukemia survivors: prevalence, viral load, and severity of liver disease. Blood 93 11 (1999) 3672-3677
174. Cesaro S., Petris M.G., Rossetti F., et al. Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 90 3 (1997) 1315-1320
175. Liang T.J., Rehermann B., Seeff L.B., et al. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132 4 (2000) 296-305
176. Lesko L.M. Surviving hematological malignancies: stress responses and predicting psychological adjustment. Prog Clin Biol Res 352 (1990) 423-437
177. Rourke M.T., Hobbie W.L., Schwartz L., et al. Posttraumatic stress disorder (PTSD) in young adult survivors of childhood cancer. Pediatr Blood Cancer 49 2 (2007) 177-182
178. Kazak A.E., Barakat L.P., Meeske K., et al. Posttraumatic stress, family functioning, and social support in survivors of childhood leukemia and their mothers and fathers. J Consult Clin Psychol 65 1 (1997) 120-129
179. Barakat L.P., Alderfer M.A., and Kazak A.E. Posttraumatic growth in adolescent survivors of cancer and their mothers and fathers. J Pediatr Psychol 31 4 (2006) 413-419
180. Reiter-Purtill J., Vannatta K., Gerhardt C.A., et al. A controlled longitudinal study of the social functioning of children who completed treatment of cancer. J Pediatr Hematol Oncol 25 6 (2003) 467-473
181. Spirito A., Stark L.J., Cobiella C., et al. Social adjustment of children successfully treated for cancer. J Pediatr Psychol 15 3 (1990) 359-371
182. Pang J.W., Friedman D.L., Whitton J.A., et al. Employment status among adult survivors in the Childhood Cancer Survivor Study. Pediatr Blood Cancer 50 1 (2008) 104-110
183. Park E.R., Li F.P., Liu Y., et al. Health insurance coverage in survivors of childhood cancer: the Childhood Cancer Survivor Study. J Clin Oncol 23 36 (2005) 9187-9197
184. Zebrack B.J., and Zeltzer L.K. Living beyond the sword of Damocles: surviving childhood cancer. Expert Rev Anticancer Ther 1 2 (2001) 163-164
185. Green D.M., Zevon M.A., and Hall B. Achievement of life goals by adult survivors of modern treatment for childhood cancer. Cancer 67 1 (1991) 206-213
186. Felder-Puig R., Formann A.K., Mildner A., et al. Quality of life and psychosocial adjustment of young patients after treatment of bone cancer. Cancer 83 1 (1998) 69-75